Heres the month-by-month breakdown based on aggregate data from 338 Phase 2 trial participants: This timeline is remarkably consistent across patients
This binding directly inhibits NPY neurons, attenuating their inhibitory effects on POMC neurons, which indirectly activates POMC neurons and decreases food intake [50]
Ida, T., Sawa, T., Ihara, H., Tsuchiya, Y., Watanabe, Y., Kumagai, Y
Combination therapy with exenatide plus pioglitazone versus basal/bolus insulin in patients with poorly controlled type 2 diabetes on sulfonylurea plus metformin: the Qatar study
Standard titration protocols increase semaglutide by 0.25 mg every four weeks, meaning it takes approximately 32 weeks (about 8 months) to progress from the starting dose of 0.25 mg to the maximum of 2.4 mg